You can buy or sell Immunic and other stocks, options, ETFs, and crypto commission-free!
Immunic, Inc. engages in developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Read More Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low